Description of the medicine: Quinagolide (Quinagolide)
(+ -) - N, N-Diethyl-N - [(3R, 4aR, 10aS) -1,2,3,4,4а, 5,10,10а-octahydro-6-hydroxy-1-propylbenzo [g] quinolin-3-yl] sulfamide hydrochloride.
Synonyms: Quinagolide, Norprolac, Norprolac.
Being a stimulant of D2-dopamine receptors, inhibits the secretion of prolactin.
Used for hyperprolactinemia, accompanied by galactorrhea, oligo- and amenorrhea, infertility and decreased libido, as well as with parkinsonism.
Assign inside 0,025 mg (25 mcg) at night, increasing the dose by 0,025 mg every 3 days to an average maintenance dose of 0.075-0.1 mg.
Possible side effects: orthostatic hypotension, dyspepsia, anorexia, abdominal pain, insomnia or drowsiness, acute psychoses, etc.
The drug is contraindicated in mental illness and breastfeeding.
Release form: tablets on 0,025; 0.05; 0.075 and 0.15 mg (N. 30).